Toshiyuki Hirakata

Japanese subject subpopulation analysis of B-LONG: a Phase 3 study of long-acting recombinant factor IX Fc fusion protein

T. Matsushita, M. Taki, M. Shima, 2015 .

Recombinant FIX Fc fusion protein activity assessment with the one‐stage clotting assay: A multicenter, assessor‐blinded, prospective study in Japan (J‐Field Study)

J. Sommer, K. Fukutake, Tomomi Kobayashi, 2019, International journal of laboratory hematology.

Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis.

J. Kira, T. Saida, Yasuhiro Ueno, 2016, Multiple sclerosis and related disorders.